Article
Single-AAV CRISPR editing of skeletal muscle in non-human primates with NanoCas, an ultracompact nuclease
2025-01-30
Abstract excerpt
CRISPR gene editing is a transformative technology for addressing genetic diseases, but delivery constraints have largely limited its therapeutic applications to liver-targeted and ex vivo therapies. Here, we present the discovery and engineering of NanoCas, an ultracompact CRISPR nuclease capable of extending CRISPR’s reach in vivo beyond liver targets. We experimentally screened 176 ultracompact CRISPR systems...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 37a7a07b-3498-5186-93cc-a4dd09b2bca5
- DOI
- 10.1101/2025.01.29.635576
